A convenient Ni(II)‐catalyzed C−C and C−N cascade couplingreaction was developed to directly access various 2,4‐disubstituted imidazoles. The reaction scope covers a variety of aryl and aliphatic substitutions, which demonstrate moderate‐to‐excellent yields. The tolerance of halogen and N‐containing heterocyclic groups demonstrates the versatility of this method for further synthetic explorations
Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as therapeutics for the treatment of cancer and other diseases.
One-Pot Synthesis of 2-Alkyl-4(5)-Aryl-1<i>H</i>-Imidazoles from 1-Aryl-2-Bromoethanones, Ammonium Carbonate and Aliphatic Carboxylic Acids
作者:Cong Liu、Yijiao Nie、Guowei Yao、Rongji Dai、Yulin Deng
DOI:10.3184/174751914x13932684206700
日期:2014.4
A simple and efficient protocol for the preparation of 2-alkyl-4(5)-aryl-1H-imidazoles starting from α-bromo aryl methylketones and aliphatic carboxylicacids in the presence of ammonium carbonate has been developed.
5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS
申请人:Dousson Cyril B.
公开号:US20110150827A1
公开(公告)日:2011-06-23
Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
METHODS FOR TREATING DRUG-RESISTANT HEPATITIS C VIRUS INFECTION WITH A 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITOR
申请人:Dousson Cyril B.
公开号:US20120252721A1
公开(公告)日:2012-10-04
Provided herein are methods for treating or preventing drug-resistant hepatitis C virus infection in a subject, which comprises administering to the subject a 5,5-fused heteroarylene hepatitis C virus inhibitor compound, for example, of Formula I, IA, or IB.